190 related articles for article (PubMed ID: 24533748)
1. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
3. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
4. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
[TBL] [Abstract][Full Text] [Related]
6. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
[TBL] [Abstract][Full Text] [Related]
8. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
9. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
10. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
[TBL] [Abstract][Full Text] [Related]
11. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
12. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
[TBL] [Abstract][Full Text] [Related]
13. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
Hattori N; Ishihara T; Saiki Y; Shimatsu A
Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
[TBL] [Abstract][Full Text] [Related]
14. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
Fahie-Wilson MN; Soule SG
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
16. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
Whitehead SJ; Cornes MP; Ford C; Gama R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
[TBL] [Abstract][Full Text] [Related]
17. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
18. A practical method for the detection of macroprolactinaemia using ultrafiltration.
Prazeres S; Santos MA; Ferreira HG; Sobrinho LG
Clin Endocrinol (Oxf); 2003 Jun; 58(6):686-90. PubMed ID: 12780743
[TBL] [Abstract][Full Text] [Related]
19. [Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG].
Jeske W; Zgliczyński W; Gorzelak K
Endokrynol Pol; 2005; 56(5):779-84. PubMed ID: 16817144
[TBL] [Abstract][Full Text] [Related]
20. Should macroprolactin be measured in all hyperprolactinaemic sera?
McKenna TJ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]